Received: 12 January 2022
Accepted: 13 April 2022
First Online: 7 May 2022
: Ethical approval was not required for any aspect of the work presented in this manuscript.
: Not applicable.
: TAP, AS, DC, LG and the International Ankle Arthroplasty Registry Committee declare no conflicts of interest. NKA has received honorariums from Novartis, Alliance for Better Health, and Lilly; held advisory board positions (which involved receipt of fees) at Merck, Merck Sharp and Dohme, Roche, Novartis, Smith and Nephew, Q-MED, Nicox, Servier, GlaxoSmithKline, Schering-Plough, Pfizer, and Rottapharm; and received consortium research grants from Alliance for Better Bone Health, Amgen, Novartis, Merck Sharp and Dohme, Servier, Eli Lilly, and GlaxoSmithKline; he has no other relationships or activities that could appear to have influenced the submitted work. The remaining authors declare no conflicts of interest in relation to this work.